Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.05 | 7.14285714286 | 0.7 | 0.7669 | 0.6946 | 435617 | 0.72594178 | CS |
| 4 | -0.1 | -11.7647058824 | 0.85 | 0.85 | 0.66 | 502377 | 0.73880264 | CS |
| 12 | -0.29 | -27.8846153846 | 1.04 | 1.08 | 0.66 | 665303 | 0.84129998 | CS |
| 26 | -0.71 | -48.6301369863 | 1.46 | 1.66 | 0.66 | 688193 | 1.0923605 | CS |
| 52 | -0.9 | -54.5454545455 | 1.65 | 2.31 | 0.66 | 966904 | 1.38525741 | CS |
| 156 | -0.79 | -51.2987012987 | 1.54 | 2.31 | 0.5 | 825787 | 1.15392452 | CS |
| 260 | -0.18 | -19.3548387097 | 0.93 | 9.8 | 0.5 | 3591977 | 3.13906313 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
